USANA Health Sciences Announces Recommendation that Shareholders Reject Amended Tender Offer

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that the Special Committee of its Board of Directors has unanimously determined that the amended tender offer announced on June 30, 2008, by Unity Acquisition Corp. is inadequate and not in the best interests of USANA’s shareholders. The tender offer, which was announced on June 2, 2008, was amended by the Purchaser on June 30, 2008, to increase the purchase price per share of common stock to $28.00, from the original $26.00 per share price.

The Special Committee made its determination after carefully considering the amended tender offer, the prospects and value of USANA, and other relevant facts and information set forth in an amendment to the Solicitation/Recommendation Statement on Schedule 14D-9/A, filed with the Securities and Exchange Commission (the “SEC”) on July 3, 2008.

The Special Committee unanimously recommends, on behalf of the Company, that the shareholders reject the amended tender offer and not tender their shares. If shareholders have previously tendered shares and wish to withdraw such shares, they should contact their broker or American Stock Transfer & Trust Company, the depository for the tender offer.

The Special Committee encourages USANA shareholders to review the amendment on Schedule 14D-9/A in its entirety, which is being mailed to the shareholders and filed with the SEC, because it contains important information. Shareholders can obtain a free copy of the amendment on Schedule 14D-9/A or other documents filed by USANA with respect to the tender offer, at www.sec.gov.